A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

NCT00001116 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tumor Necrosis Factor soluble receptor-immunoadhesin complex

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)